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Nasopharyngeal carcinoma (NPC) samples of
distinct bistological types, including squamous
ceU carcinoma (WHO type 1), nonkeratinizing
carcinoma (WHO type 2), and undifferentiated
carcinoma (WHO type 3), were analyzed for
Epstein-Barr virus (EBV) infection and gene ex-
pression by using in situ and biochemical tech-
niques. The EBV-encoded RNAs (EBER) were de-
tected in situ in most tumor ceUs ofaU three WHO
types ofNPC Infoci ofsquamous differentiation
and keratinization within less differentiatedNPC
and throughout the expanse of weU differenti-
ated squamous ceU carcinoma, EBER expression
was less abundant. Latent membrane protein, an
EBV-encoded membrane protein, was detected in
72% (36/50) ofaUNPCand 67% (6/9) ofthe cases
of squamous ceU carcinoma. The EBV genomes
were present as clonal episomalforms, without
detectable linear viral DNA, in aU cases ofsqua-
mous ceU carcinoma analyzed. Polymerase chain
reaction amplification ofcDNA detectedEBVtran-
scription for Epstein-Barr nuclear antigen 1, la-
tent membrane proteins I and 2, and BamHIA in
aU samples, indicating that allforms ofNPC ex-
press the same EBV genes. these results reveal
that EBER expression is significantly decreased
in areas with squamous differentiation and con-
firm that aU types of NPC, regardless of histo-
logical type or differentiation contain clonal epi-
somal EBVgenomes, express specific EBVgenes,
and are a clonal expansion ofEBV-infected ceUls.
(Am J Pathol 1995, 146-1355-1367)
Nasopharyngeal carcinoma (NPC) is an epithelial tu-
mor that occurs worldwide but is characterized by
marked geographical and population differences in
incidence.1 It is rare among Europeans and North
American Caucasians, with an age-adjusted inci-
dence rate of less than 1/100,000. It develops with
high incidence in southern China and southeast Asia,
where it may represent 25% of all cancers. In southern
China, the age-adjusted incidence rate is approxi-
mately 25/100,000 for males in Hong Kong.2 The tu-
mor also occurs with increased incidence in other
Chinese populations and in Alaskan Eskimos and with
intermediate incidence in Mediterranean Africans.3
NPC has been classified into three types by the
World Health Organization (WHO): squamous cell
carcinoma (SCC, WHO type 1), nonkeratinizing car-
cinoma (NKC, WHO type 2), and undifferentiated car-
cinoma (UC, WHO type 3).4 The classification is en-
tirely on the basis of light microscopic appearances
of the tumor cells. SCCs are tumors in which evidence
of keratinization is unequivocally present as evi-
denced by the presence of intercellular bridges and
the production of keratin, either intracellular or extra-
cellular. In common with SCCs that occur elsewhere
in the body, SCC of nasopharyngeal origin may be
graded as well, moderately, or poorly differentiated
cancers. A desmoplastic reaction to invading tumor
cells is common, and the intense infiltrating lympho-
cytes, so conspicuous in the other histological types
of NPC, are often lacking in SCC. NKC and UC are
distinguished from SCC by the failure to demonstrate
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evidence of squamous differentiation on light micros-
copy. Tumor cells in NKC generally exhibit a pave-
mented or stratified arrangement, and individual tu-
mor cells are separated by clearly defined cell
margins. In UC, cell borders are indistinct and tumor
masses appear as syncytia in sheet-like masses. A
characteristic and striking feature is vesicularity of the
nuclei and the presence of prominent nucleoli in UC
cells. Additionally, in NKC and UC, a substantial lym-
phoid infiltrate is frequently present. NKC and UC of
the nasopharynx, but not SCC, have been tradition-
ally associated with Epstein-Barr virus (EBV) infec-
tion, as patients have elevated immunoglobulin (1g)G
and IgA titers to the viral capsid antigen and to the
diffuse component of the early antigen.56 In contrast,
patients with SCC have serological profiles similar to
those of control populations. In some studies, EBV
DNA and EBV nuclear antigen (EBNA) have been de-
tected only in UC and NKC but not in SCC. However,
EBV DNA was found in two of four tumors with regions
of differentiation.78 EBV DNA was detected in low
copy number on Southern blots in five of five cases
of well differentiated SCC.9 The DNA from one of the
samples was cloned, and a recombinant fragment
representing the fused viral termini was obtained, in-
dicating the presence of covalently closed episomal
viral DNA in the tumor.
This study was undertaken to further characterize
the rare SCC arising in the nasopharynx and to as-
certain its association with EBV. In situ hybridization
(ISH) for the EBV-encoded RNAs (EBERs) and im-
munohistochemical detection of the EBV latent mem-
brane protein (LMP-1) were utilized to identify EBV-
infected cells and to determine the relationship
between differentiation and the presence of EBV.
Larger samples were also analyzed to determine the
viral DNA structure and to identify the EBV genes ex-
pressed in these tumors. The data indicate that all
forms of NPC are uniformly infected by EBV and con-
tain homogeneous, clonal EBV genomes. In all forms
of NPC, the same set of specific EBV genes were
expressed with an apparent decrease in EBER abun-
dance in areas of differentiation. The demonstration of
clonal EBV and the consistent expression of specific
EBV genes suggest that regardless of the state of




A total of 5326 nasopharyngeal biopsies were
screened for examples of NPC, from which 1800
samples of histologically confirmed NPC were iden-
tified. The patients were predominantly Chinese with
a small number of Malay (172) and Indian (20) pa-
tients. All samples of SCC analyzed in this study were
from Chinese patients. The nasopharyngeal biopsies
were examined histologically and classified accord-
ing to established WHO criteria. In all, 320 cases
(17%) of SCC were identified, of which 4 were ex-
amples of well differentiated SCC. The other cases
were either moderately (174 cases) or poorly (142
cases) differentiated. Of these, 31 cases were se-
lected for further study by both biochemical and in
situ analyses. Included were all 4 cases of well dif-
ferentiated SCC, 20 cases of moderately differenti-
ated SCC, and 7 cases of poorly differentiated SCC.
In addition, a prominent squamous or keratinizing
component was identified in 360 biopsies of NPC of
mixed histological type. Several types of analyses
were performed on the collected tissues, although the
types of analyses that could be performed on a given
sample were limited by the sample size. Small speci-
mens were studied by in situ analyses. There were 4
samples of SCC that were large enough for biochemi-
cal studies, including 2 examples of well differenti-
ated SCC (samples 156 and 200) and two examples
of moderately differentiated SCC (samples 159 and
453).
EBER ISH
To detect expression of the small nuclear RNAs, the
EBERs, ISH with fluorescein-conjugated oligonucle-
otide probes was used. The probes were obtained
commercially and consisted of a mixture of both
EBER-1 and EBER-2 (Dako Corp., Carpinteria, CA).
Pretreatment of the slides included soaking in ethanol
acetone (1:1 v/v), baking at 100 C, incubating in 3x
SSC (sodium-buffered citrate), 1 x Denhardt's solu-
tion (0.02% polyvinylpyrrolidone, 0.02% Ficoll, 0.02%
bovine serum albumin) for 3 hours at 65 C, dipping in
1 % poly-L-lysine or 2% organosilane in acetone for 5
minutes, and storage at -70 C. The tissue sections,
4 to 5 p thick, were placed on the slides, rehydrated,
and air dried before they were treated with proteinase
K in a solution of Tris-buffered saline (TBS) and
washed and air dried again. The tissue sections were
hybridized for 2 hours at 37 C in a 15 to 30-pl volume
and washed in TBS (0.05 mol/L Tris/HCI, 0.15
mol/L NaCI, pH 7.6). Detection of hybridization uti-
lized alkaline phosphatase-conjugated rabbit anti-
fluorescein isothiocyanate antisera and was visual-
ized by the colorimetric reaction of the enzyme
conjugate with the substrate 5-bromo-4-chloro-3-
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indoyl phosphate and the concomitant reduction of
nitroblue tetrazolium.
LMP- 1 Immunostaining
LMP-1 was identified with a pool of four anti-LMP-1
monoclonal antibodies (CS1-4) that were obtained
commercially (Dako Corp.). The antibodies were de-
tected with a secondary antibody that was tagged
with immunoperoxidase. The formalin-fixed paraffin-
embedded tissue sections were deparaffinized and
rehydrated. A solution of 3% hydrogen peroxide was
used to quench endogenous peroxidase activity, and
the sections were rinsed in TBS. The sections were
reacted with the primary antibody at a 1:50 dilution for
30 minutes, washed twice in TBS, reacted with bioti-
nylated goat anti-mouse Ig for 30 minutes, and
washed in TBS. The complex was detected with a
streptavidin/horseradish peroxidase complex and in-
cubated with diaminobenzidine tetrahydrochloride,
which produces a dark brown precipitate.
Assessment of EBV Clonality
Tissue samples were processed as previously de-
scribed, with purification of DNA and RNA through a
CsCI step gradient.10 To determine the EBV genome
copy number and to identify the EBV termini, South-
ern blots were prepared with dilutions of Raji DNA
representing 1, 5, and 50 copies of episomal DNA
and sample DNA digested with BamHl. The blots
were hybridized with the Xhola probe, representing
unique DNA adjacent to the terminal repeats as de-
scribed previously.11
PCR Analysis of EBV Transcription
To analyze EBV expression, 2 pg of sample RNA was
used to prepare cDNA. The RNA was annealed to 0.5
pg of a 20-mer oligodeoxythymidine primer by heat-
ing to 70 C for 10 minutes, followed by incubation on
ice. Reverse transcription was performed in a 20-p1
reaction volume at 45 C with Superscript 11 reverse
transcriptase (Life Technologies, Gaithersburg, MD)
according to the manufacturer's instructions. Equiva-
lent aliquots of RNA were processed in parallel with-
out addition of enzyme to serve as a negative control.
The cDNA was amplified by polymerase chain reac-
tion (PCR) with oligonucleotide primers that span
splices that are unique and distinguish each of the
EBV mRNAs, as previously described (Table 1).12
Negative controls containing all PCR reagents and
water instead of template were included for all reac-
tions. The PCR products were resolved by electro-
phoresis through 1% agarose gels with DNA molecu-
lar weight standards and transferred to nitrocellulose.
Hybridizations were performed at 45 C with approxi-
mately 106 cpm/ml 32P-end-labeled oligonucleotides
and washed at 45 C in 1x SSC and 0.1% sodium
dodecyl sulfate.
Results
Histology and in Situ Identification of
EBER RNAs
An example of moderately differentiated SCC
(sample 453) exhibited discrete islands of tumor cells
with definite light microscopic evidence of squamous
Table 1. Sequences of the Oligonucleotide Primers
Specificity B95-8 coordinates Primer sequence
EBNA-1 67544-67563 5'-AGAGAGTAGTCTCAGGGCAT-3'
108051-108032 5'-TCTTCTTTGAGGTCCACTGC-3'
EBNA-1 probe 107994-107975 5'-TCCTAGGCCATTTCCAGGTC-3'
EBNA-2 47940-47959 5'-GCGCCAATCTGTCTACATAG-3'
48534-48515 5'-CCCCATGTAACGCAAGATAG-3'
EBNA-2 probe 48473-48454 5'-CGGGTGCTTAGAAGGTTGTT-3'
LMP-1 168666-168686 5'-AGTTAGAGTCAGATTCATGGC-3'
169305-169285 5'-CCTTTGCTCTCATGCTTATAA-3'
LMP-1 nested 168888-168908 5'-GGAAGAAGGCCAAAAGCTGCC-3'
169263-169243 5'-TCTTCAGAAGAGACCTTCTCT-3'
LMP-1 probe 168888-168908 5'-GGAAGAAGGCCAAAAGCTGCC-3'
LMP-2A 166820-166840 5'-GATTGCAACACGACGGGAATG-3'
LMP-2A 271-251 5'-AAGTGACAACCGCAGTAAGCA-3'
LMP-2 probe 229-249 5'-AAACTGCTGACACCGGTGACA-3'
BamHI A 157313-157332 5'-GTTTTGCGCCTGGAAGTTGT-3'
BamHI A 160387-169370 5'-GGCTGACTCACCTGTTTG-3'
BamHI A probe 159190-159171 5'-AGCTTTCCTTTCCGAGTCTG-3'
ZEBRA 102248-102267 5'-TCCGGGGGATAATGGAGTCA-3'
ZEBRA 102685-102666 5'-ACGCACACGGAAACCACAAC-3'
ZEBRA probe 102531-102518 5'-GCTGGAGGAATGCG
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Figure 1. Histology and EBER ISH ofNPC. A: SCC of the nasopharynx (sample 453) NPC WHO type 1, moderately differentiated (hematoxylin and
eosin; magnification, x 200). The tumor cells are present as ill-formed squamous islands with many cells with spindle cell morphology. A desmo-
plastic stromal reaction is apparent, and occasional scattered lymphocytes are present in the stroma. B: EBER ISH ofSCC 453 (x 400). Most of the
spindle-shaped tumor cells have dark nuclearpositivity of variable intensity. In a more differentiatedfocus, in the lower left of thefield, EBERs were
detected in some cells. C: EBER ISH in moderately differentiated WHO type 1 NPC (X 400). In the periphery of the tumor nest, there is evidence of
differentiation to maturation evidenced by the increase in size of the tumor cells and the increased clear cytoplasm. Most of the tumor cells within
the keratinizing focus in the lower left had weakly detectable EBER signals. In contrast, most of the smaller, less differentiated tumor cells in the
center of the tumor had strong EBER positivity. The stroma was negativefor hybridization. D: EBER ISH to NPC with mixed histology (x 400). The
intensely EBER-positive tumor cells on the left consist ofpredominantly undifferentiated cells typical ofNPC WHO type 3. A differentiated focus of
keratinizing tumor cells is present in the right half of the section and has a striking reduction in the intensity ofEBER hybridization, uwith EBER
hybridization present in some cells and others staining weakly or not at all. Erythrocytes and lymphocytes in the tumor periphery and at the inter-
face of the two types ofNPC did not hybridize to the probe. E: EBER ISH of wvell differentiated SCC 156 (X 400). Keratin whorlformation is evident
in this section. The EBER signals are weak throughout the section and arefaint or absent within the keratinizing centers of the tumor whorls (ar-
rows). F: EBER ISH ofNKC, WHO type 2 (X 400). The tuimor cells are present in confluent cords of cells, forming ill-defined masses with most cells
intensely positive for EBER hybridization. The intervening clear areas are fibrous septae that did not hybridize to the EBER probe. 7The dark bar
present in the panels is the image of the camera databack. The differences in background color are caused by differences in color balancinzg in
different microscopes. All EBER ISH were photographed without counterstaininig to emphasize the absence of nonspecific hybridization.
differentiation. The majority of tumor cells were pre-
dominantly of the spindle cell type (Figure 1A). A
prominent desmoplastic stromal reaction was evi-
dent, and occasional scattered lymphocytes were
detected in the stroma.
The small nuclear EBERs are the most abundant
RNA in latently infected cells and may be present at
106 copies per cell. 13,14 They are readily detected by
EBER ISH. The EBERs are not expressed in the virus-
producing EBV infection, oral hairy leukoplakia, and
are consistently detected in NPC.15 16 A parallel sec-
tion of the tumor tissue presented above, SCC 453,
was hybridized to single-stranded oligonucleotide
probes, conjugated with FITC, homologous to the
EBER1 and EBER2 RNAs. Within the tumor tissue,
strong EBER positivity was localized to the nucleus in
0
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the majority of the tumor cells. Hybridization was not
detected to the intervening fibrous stroma (Figure
1 B).
In a second example of a moderately differentiated
SCC, multiple keratinizing foci were detected
throughout the expanse of the tumor. In an example
of one such keratinizing focus, the cells within the
areas of differentiation are larger, with clearly defined
cell borders and increased cytoplasmic volume (Fig-
ure 1C). The nuclei of these maturing cells are small
and central, with regular margins. Hybridization with
the EBER probe revealed variable intensity with de-
creased signal in the keratinizing focus (Figure 1C).
This decrease in intensity was particularly evident in
the periphery of the tumor nest where the tumor cells
appeared more differentiated. The remaining moder-
ately differentiated tumor cells within the center of the
tumor were smaller with increased nuclear/
cytoplasmic ratios and exhibited strong EBER sig-
nals. Hybridization was not detected in the adjacent
fibrous stroma.
In any large series on NPC, a substantial proportion
of tumors demonstrate mixed histological types of
NPC.17,18 In an example of a hybrid histological type
of coexistent UC and SCC, EBER ISH revealed strong
hybridization within the nuclei of the UC cells. In con-
trast, the cells of the adjacent SCC had a weaker but
clearly identifiable hybridization signal within the tu-
mor nuclei (Figure 1D). This result indicated a de-
creased amount of EBER expression in areas of dif-
ferentiation.
Well differentiated SCC of the nasopharynx is ex-
tremely rare but is easily recognized and resembles
well differentiated SCC elsewhere in the head and
neck region.17-19 Abundant keratin production, ker-
atin whorl formation, and easily identifiable intracyto-
plasmic keratin within the tumor cells are typical fea-
tures. An example of well differentiated NPC (sample
156) exhibited the characteristic abundant cytoplasm
and keratin whorls. Positive hybridization with the
EBER probe was detectable with variable intensity
throughout the section. Within the well differentiated
whorls, identified by arrows, most cells appeared
EBER negative, again suggesting the down-
regulation of EBER expression in areas of differentia-
tion (Figure 1 E). The low level of expression within this
well differentiated tumor sample was strikingly dis-
tinct from the intense EBER staining that is charac-
teristic of both NKC (WHO type 2) and UC (WHO type
3) types of NPC (Figure 1 F).
In summary, the EBER ISH indicated that all ex-
amples of WHO 1 tumors, regardless of the degree of
differentiation, were positive for EBER expression as
were all examples of NKC and UC (Table 2). These
data indicate that all forms of NPC are infected with
EBV and confirm the previous studies that identified
EBV in SCC.9 The readily apparent difference in EBER
intensity may account for the inability to detect EBV or
EBER expression in some of the previous studies.20
Detection of EBV Latent Membrane
Protein in Situ
The EBV latent membrane protein LMP-1 is the only
EBV gene with transforming properties in cell
lines.21,22 LMP-1 expression has been detected in
approximately 65% of NPC biopsy tissues.23 24 In this
study, staining with a pool of monoclonal antibodies
to LMP-1 detected LMP-1 expression in 50% (2/4) of
the well differentiated SCC samples and in 75% (3/4)
of the moderately differentiated SCC samples. LMP-1
was also detected in 73% (30/41) of the NKC and UC
samples (WHO types 2 and 3; Table 2).
Detection of LMP-1 was evident in most cells of all
types of NPC (Figure 2). In an example of moderately
differentiated NPC (sample 159), LMP-1 expression
was clearly evident with coarse granular staining of
the cytoplasm of most of the tumor cells. The scat-
tered mononuclear cells and the adjacent stroma
were negative (Figure 2A). Most cells within a second
example of moderately differentiated SCC (sample
453) were also positive for LMP-1 with granular stain-
ing throughout the abundant cytoplasm. The infiltrat-
ing lymphocytes were negative (Figure 2B). These
data indicated that EBV is present within the malig-
nant epithelial cells and not in the infiltrating lympho-
cytes.
Table 2. Analysis ofNPC by EBER ISH and LMP-1 Immunostaining
EBER LMP-1
WHO type Number % Number %
1 (well differentiated) 4/4 100 2/4 50
1 (moderately differentiated) 20/20 100 3/4 75
1 (poorly differentiated) 7/7 100 1/1 100
1 (total) 31/31 100 6/9 67
2 and 3 89/89 100 30/41 73
Total 120/120 100 36/50 72
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Figure 2. LMP-1 immunostaining in NPC
WHO type 1. A: Sample 159 (x675). LMP-1
was detected in most tumor cells as evidenced
by the presence of brown granular staining of
the cellular cytoplasm. The adjacent fibrous
stroma and scattered mononuclear cells did
not stain. B: Sample 453 (x675). The cyto-
plasm of the tumor cells was uniformly positive.
In contrast, occasional infiltrating lymphocytes
are clearly negative.
EBER ISH and LMP-1 immunostaining were per-
formed in histologically normal biopsies of the post-
nasal space of various categories of patients and
were consistently negative (data not shown). The con-
trol cases included samples from patients suspected
of having nasopharyngeal lesions but presenting with
normal or reactive mucosa on biopsy, patients with
high risk for developing NPC, and adjacent normal
mucosa of patients with NPC.
Identification of the EBV Termini
EBV virion DNA is a double-stranded linear mole-
cule with multiple, variable numbers of copies of a
direct tandem repeat of approximately 500 bp at
each terminus. When treated with restriction en-
donucleases, arrays of heterogeneous restriction
fragments are produced that vary by increments of
500 bp.25,26 The ends of the linear termini fuse after
infection to form the covalently closed episomal
intracellular DNA. Although these fragments are
potentially very heterogeneous, single fused ter-
minal restriction fragments were detected in NPC
and in Burkitt's lymphoma.11 The detection of a ho-
mogeneous fragment indicated that the viral epi-
somes within a cell were clonal with regard to the
number of terminal repeats and suggested that
clonality of the EBV episome could be used as a
predictor of cellular clonality. The correlation be-
tween viral and cellular clonality has been proven
in studies of lymphoid cell lines.27 Other malignan-
cies associated with EBV, including Hodgkin's dis-
ease and T cell lymphomas, have also been shown
to contain clonal EBV termini, and oligoclonal
proliferations have been detected in immunosup-
pressed patients. 12,28
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Frozen tissue samples were available for biochemi-
cal analyses from four examples of well and moder-
ately differentiated SCC. These samples were pro-
cessed to obtain DNA and RNA. Southern blots
prepared with sample DNA digested with BamHl and
dilutions of Raji DNA representing approximately 50,
5, and 1 copies of EBV per cell were hybridized to the
Xhola probe that represents the unique DNA adjacent
to the terminal repeats at the right end of the genome.
A single EBV terminal restriction enzyme fragment
was detected in all four samples of well and moder-
ately differentiated SCC, which were also positive for
EBER and LMP-1 expression (Table 3, Figure 3). Lad-
der arrays of smaller fragments that are indicative of
viral replication were not detected in any of these
samples. The detection of a single EBV terminal frag-
ment suggests that these examples of SCC are clonal
proliferations of a latently EBV-infected cell.
PCR Analysis of EBV Transcription
Multiple EBV genes are expressed in latently infected
lymphocytes. These include six nuclear antigens and
two integral membrane proteins.29 The EBV latent
mRNAs are intricately spliced with distinct exon pat-
terns for each of the transcripts.29 The six nuclear
antigens, EBNAs, are encoded by a large primary
transcript that is differentially spliced for each of the
individual mRNAs. The PCR has been used to detect
the specific splices of the EBV mRNAs, by using oli-
gonucleotide primers that span the introns of the in-
dividual mRNAs. 1230,31 PCR analysis of cDNAs was
used to screen for the specific splices that distinguish
the EBNA-1, EBNA-2, LMP-1, and LMP-2 mRNAs and
transcription of BamHl A, all of which are expressed
in latently infected lymphoid cell lines.28,30,32,33 PCR
primers were also used to detect the mRNA encoding
the EBV replication activator gene, ZEBRA.34 For all
PCR analyses, equal aliquots of RNA were used to
prepare cDNA with and without reverse transcriptase
to serve as a negative control.
The EBNA-1 protein binds to the latent origin of
replication and is required for replication of the EBV
episome.35 EBNA-1 is expressed in all latently in-
fected cells, including the epithelial cells of NPC. Se-
quence analysis of cDNAs indicated that all EBNA-1
mRNAs contain an exon within the BamHl U frag-
ment.3637 To specifically detect the EBNA-1 mRNA,
oligonucleotide amplimers were chosen that span a
40-kb intron within the mRNA from BamHl U to the
coding sequences within BamHl K. The EBNA-1
mRNA is present in low abundance but is readily de-
tected by PCR amplification. Amplification of con-
taminating DNA or unprocessed and unspliced
mRNA is prohibited by the large size of the intron. In
the four samples of SCC, the 216-bp product repre-
senting the spliced EBNA-1 transcript was detected
by hybridization with an EBNA-1-specific oligonucle-
otide probe (Table 3, Figure 4A).
EBNA2 is a transcriptional transactivating protein
that is essential for B lymphocyte transformation in
vitro.3840 The protein has not been detected in NPC
or in EBV-positive T cell and Hodgkin's lymphomas
but has been identified in post-transplant lympho-
mas. 12,28.41.42 The EBNA-2 mRNAs include exons
from the BamHl W, Y, and H fragments. The EBNA-2
mRNA splices from the Y2 exon to the EBNA-2 YH
coding exon. Amplification with oligonucleotide prim-
ers for this splice and hybridization with an EBNA-2-
specific oligonucleotide probe did not produce any
detectable product (data not shown). Therefore, in
contrast to EBNA-1, transcription of the EBNA-2 gene
was not detected in the three examples of SCC that
were tested. The lack of detectable EBNA-2 transcrip-
tion in all types of NPC indicates that EBNA-2 expres-
sion is not required for maintenance or regulation of
latent EBV infection in epithelial cells and apparently
does not contribute to the altered growth properties
of the epithelial cells.
The EBV genes expressed during latency have
been primarily defined in lymphoblastoid cell lines.29
However, an abundant family of transcripts, partially
encoded by the BamHl A fragment, was identified in
NPC. These transcripts are present at much higher
levels in NPC than in lymphoid cell lines.32'33,43 The
BamHl A transcripts are intricately spliced, and mul-
tiple different RNA forms have been detected.3233
BamHl A transcription has previously been detected
Table 3. Results of Clonality Assay and Reverse Transcriptase-PCR Analysis of WHO Type 1 NPC
Sample EBER LMP-1 Clonal Reverse transcriptase-PCR
No. ISH IS termini EBNA-1 LMP-1 LMP-2 BamHl A EBNA-2 BZLF-1
156 + + + + + + + - -
200 + + + + + + ND ND ND
453 + ++ + + + + + - -
159 + ++ + + + + + - -
ND, not determined.
1362 Pathmanathan et al
AJPJune 1995, Vol. 146, No. 6
R50 R5 Rl 159 156 200 453
Figure 3. Identification of EBV DNA in SCC.
Histologically proven samples ofSCC were pro-
cessed to obtain DNA. Southern blots prepared
with sample DNA digested with BamHI were hy-
bridized to a single-stranded RNA probe from
the XhoIa fragment in comparison with dilu-
tions of Rafi DNA representing 50, 5, and 1
copy of EBV DNA per cell. In each sample, a
single restriction enzyme fragment was de-
tected, suggesting clonal episomalforms ofEBV
DNA.
in all NPC samples tested.3043 In this study, oligo-
nucleotide primers that span one of the introns from
the abundant 4.8-kb BamHI A mRNA were used to
detect expression. Hybridization with a BamHl A oli-
gonucleotide probe detected the 350-bp product
representing processed BamHl A transcription in the
three samples of SCC that were tested (Table 3, Fig-
ure 4B).
LMP-1 is an integral membrane protein and is the
only EBV gene product that has transforming prop-
erties in vitro.21'22 LMP-1 is essential for EBV-induced
lymphocyte transformation44 and has been detected
on immunoblots in approximately 65% of NPC
samples23'24 and in this study was detected in 72%
of the samples by immunohistochemistry (Table 2). To
detect LMP-1 mRNA, two sets of nested amplimers
were chosen that span the two LMP-1 introns. The
amplification product representing genomic LMP-1
DNA or unprocessed RNA is 375 bp whereas a
222-bp product is generated from the spliced LMP-1
mRNA. The 222-bp product was detected by hybrid-
ization in all four cDNA samples but was not detected
in the control amplifications (Figure 5A, Table 3) pre-
pared without reverse transcriptase. This result was
consistent with the immunohistochemical detection of
the LMP-1 protein. The consistent detection of LMP-1
in all forms of NPC suggests that its expression con-
tributes to the altered growth properties of the neo-
plastic cells.
The LMP-2 proteins, LMP-2A and LMP-2B, are also
integral membrane proteins that associate with
LMP-1 in the plasma membrane.45 In lymphocytes,
LMP-2A binds to the lyn and fyn tyrosine protein ki-
nases and blocks signaling through the Ig receptor.
This inhibition of lymphocyte activation blocks induc-
tion of replicative gene functions and helps maintain
a latent infection.46 Transcription of LMP-2A is con-
sistently detected in NPC.30,31 The LMP-2 genes con-
tain exons from both ends of the linear EBV genome
and can only be transcribed across the fused termini
of the episomal form.47'48 Primer pairs were utilized
that span the fused termini of EBV from exon 1A to
exon 2. Hybridization with an exon 2-specific probe
detected the 312-bp product, indicative of transcrip-
tion of LMP-2A mRNA, in all four SCC samples (Figure
5B, Table 3). Normal epithelial cells are thought to be
permissive for viral replication; therefore, the consis-
tent expression of LMP-2A in NPC suggests that it
may also contribute to maintenance of latent infection
in epithelial cells.49
The EBV replication activator gene, ZEBRA, is the
single viral gene responsible for activating the cas-
cade of viral expression leading to permissive, rep-
licative infection.34 The protein is encoded by three
exons; therefore, oligonucleotide primers were cho-
sen that span the two introns (Table 1). Amplification
and hybridization with the ZEBRA-specific oligo-
nucleotides did not produce any detectable product
(data not shown). It is thought that differentiation of
epithelial cells may activate viral replication; however,
the lack of ZEBRA expression in these examples of
differentiated NPC indicated that these infections are
predominantly latent, in agreement with the absence
of linear forms of viral DNA in the termini analyses
(Figure 3).
Discussion
In most large series of NPC samples, SCC or WHO
type 1 NPC is the least common type of NPC and in
EBV Infection in All Forms of NPC 1363
AJPJune 1995, Vol. 146, No. 6
RT:
j5_i 159
+ + -m +
350 bp -_
this study represented 17% of the NPC samples ana-
lyzed. In contrast to SCC occurring in other regions of
the head and neck region such as the tongue, hy-
popharynx, and larynx, well differentiated SCC of the
nasopharynx is exceedingly uncommon. In a review
of 1000 consecutive cases of NPC in Taiwan, not one
case of well differentiated SCC were detected,19 and
in a separate study only 7 cases of well differentiated
SCC were found, with the majority of the cases being
either moderately or poorly differentiated.50 The in-
cidence of well differentiated SCC in this study was
0.2% (4/1800) of the total number of NPC cases.
WHO type 1 NPC has generated much controversy
because of conflicting data concerning its associa-
tion with EBV. Earlier studies demonstrated elevated
IgG and IgA titers to viral capsid antigen and early
Figure 4. Transcription ofEBNA-1 and BamHI
A. Equal aliquots ofRNA were used to prepare
cDNA with (RT+) or without (RT-) reverse
transcriptase. A: Detection of EBNA-1 mRNA.
Oligonucleotide probes from the BamHI U and
BamHI K fragments were used to detect the
EBNA-1 mRNA. The EBV BamHIfragments are
denoted above. Tbe hatched bar represents the
EBNA-1 coding sequences. The spliced EBNA-1
mRATA is represented by a 216-bp PCR product
that was detected in allfour samples analyzed.
B: Detection of BamHI A transcription. The
structure of the abundant 4.8-kb mRNA is
shown with the specific splice characteristic of
this mRNA. 7Te splicedproduct representing the
rightward BamHI A transcript is 350 bp and
was detected in all samples analyzed.
antigen in patients with WHO types 2 and 3 NPC,
whereas patients with WHO type 1 tumors tended to
have serological profiles similar to that of control
populations.5'6 It has been suggested, on the basis of
serological data and earlier EBV DNA hybridization
studies, that SCCs and undifferentiated carcinomas
are different diseases.51 Although some studies have
been unable to demonstrate the presence of EBV in
SCCs of the nasopharynx,20 others have demon-
strated that this form of NPC is EBV associated.9'52'53
In the previous studies that did not detect EBV, ISH
was used to demonstrate viral presence. In a sample
of 87 NPCs, which included 8 cases of SCC, EBV DNA
was not detected in any of the SCC samples, although
an addendum reported that EBV DNA was detected
by PCR amplification in 1 case of SCC.20 However, in
A. EBNA1
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Figure 5. Expression ofLMP-1 and LMP-2A in
SCC NPC. A: Detection of the LMP-1 mRNA. The
location of the LMP-1 coding sequences near
the right end of the linear genome and the
structure of the mRNA with the exons thatform
the LMP-1 open reading frame are indicated.
Amplification of the spliced LMP-1 mRNA or
genomic DNA produces 222-bp or 375-bp prod-
ucts, respectively. The spliced mRtVA was de-
tected in all four samples analyzed. B: Detec-
tion of the LMP-2A mRNA. The LMP-2 genes are
transcribed across the termninal repeats. Ampli-
fication from the first exon of the LMP-2A
mRNA from the right end of the linear genome
to the second exon at the left end of the linear
genome generates a 312-bp PCR product that





that study, EBV DNA was detected in only 68/77
cases of UC and in only 1 case of NKC, raising con-
cerns about the sensitivity of detection in this study.
This is supported by the fact that the authors were
able to amplify by PCR DNA from 7 cases of UC, one
of which had been negative for EBV DNA by ISH. In
another study, EBV DNA was demonstrated in 8
cases of well differentiated squamous carcinoma of
the nasopharynx by DNA slot blot hybridization (5/8
positive) and PCR analysis (6/8 positive).54 In addi-
tion, two recent studies consistently detected EBV in
all NPC cases tested, including 1 case of keratinizing
carcinoma52 and by ISH in 3 cases of well differen-
tiated SCC of the nasopharynx.53 DNA was detected
in most tumor cells of NKC and UC but was demon-
strable in only some of the WHO type 1 tumor cells.52
It is possible that the failure to detect EBV DNA re-
flects the sensitivity of the ISH assay, which is not as
high in tissue sections as in the cell lines used as
controls.
It has been suggested that the biochemical de-
tection of EBV DNA in SCC reflects the presence of
EBV-infected lymphocytes in the mucosal lymphoid
tissue of the nasopharynx. However, histological
studies have shown that such lymphoid infiltrates are
rare in SCC,7,50 and the data presented here reveal
that EBV is specifically localized to the epithelial cells
and clearly absent from the infiltrating lymphocytes.
EBER ISH was used for analysis because this type
of analysis permits visualization of morphology, al-
lows simultaneous assessment of the integrity of the
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cific tissues, cells, or even cellular compartments.
EBER ISH permits evaluation of gene expression in
paraffin-embedded tissue sections.16 The results of
the present study demonstrate that EBERs are ex-
pressed in most cells of NPC including the well dif-
ferentiated SCC. However, the abundance of EBERs
in SCC was clearly lower than that observed in NKC
and UC. These results suggest that there is a reduc-
tion in EBER detection in the maturing, differentiating
cells, a phenomenon demonstrated dramatically in
the case of mixed carcinoma (Figure 1 D). This finding
would suggest that EBER expression may be down-
regulated once tumor cells differentiate and produce
keratin.
Parallels may be drawn with the molecular events
that occur in SCC and in oral hairy leukoplakia, a per-
missive, virus-producing EBV infection of the lingual
and buccal mucosa in human immunodeficiency
virus-infected individuals. Oral hairy leukoplakia is a
characterized by abundant keratin production with
proliferation of the squamous epithelium. The viral in-
fection is unique in EBV pathogenesis in that the in-
fection is permissive with the production of linear viral
DNA and expression of LMP-1 and replicative anti-
gens in the absence of EBER expression.15 A similar
situation may occur in the SCC lesions in which dif-
ferentiation could inhibit EBER expression.
Careful histological studies have indicated that the
different histological types of NPC are variants of a
homogeneous group of neoplasms.55 Histogeneti-
cally, all NPC is squamous in origin, and this essential
squamous nature of both NKC and UC has been con-
firmed by both electron microscopy and immunohis-
tochemistry.49.50 Dedifferentiation in tumors is known
to occur in sarcomas.56 This phenomenon is well rec-
ognized in NPC, and it is not unusual for lesions that
recur, or tumors metastatic to lymph nodes, to dem-
onstrate histological features that differ from those ob-
served at the time of initial diagnosis. Shanmugarat-
nam et a150 found that 8% of the UC and 26% of the
NKC presented as SCC when the lesions recurred or
metastasized. Similarly, 50% of the tumors initially di-
agnosed as SCC recurred as either NKC or UC. From
the morphological point of view, the existence of
mixed histological types of NPC and the phenomenon
of dedifferentiation in the clinical course and biologi-
cal evolution of NPC are persuasive arguments for the
histogenetic commonality and relatedness of all three
WHO types of NPC.
All four examples of well differentiated SCC ana-
lyzed here had clonal forms of the EBV episome
without evidence of linear DNA. The IgA viral cap-
sid antigen titers were not elevated in these pa-
tients. The combined results of the reverse tran-
scriptase PCR analyses and the LMP-1
immunohistochemistry indicate that EBNA-1,
LMP-1, LMP-2, and BamHI A are consistently tran-
scribed in SCC. EBV gene transcription in latently
infected lymphoid and epithelial cells is complex,
although there are clearly specific viral-epithelial
cell interactions.3 However, despite the apparent
differences in the morphological appearances of
the three types of NPC, the identity of their histo-
genetic origin and squamous nature, the frequent
admixture of varying histological types of NPC
within a single tumor, and the demonstration of
dedifferentiation suggest that there are greater
similarities than differences between the forms of
NPC. The commonality of all three forms of NPC is
further reinforced by the results presented here
with the demonstration of clonal EBV in the cases
of well differentiated SCC and the pattern of EBV
expression identical to that which has been de-
scribed for NKC and UC. The overall conclusion,
on the basis of epidemiological, pathological, and
molecular biological grounds, is that all types of
NPC are variants of an EBV-associated malig-
nancy.
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